Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9308821rdf:typepubmed:Citationlld:pubmed
pubmed-article:9308821lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:9308821lifeskim:mentionsumls-concept:C0015895lld:lifeskim
pubmed-article:9308821lifeskim:mentionsumls-concept:C1704353lld:lifeskim
pubmed-article:9308821lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:9308821pubmed:issue8lld:pubmed
pubmed-article:9308821pubmed:dateCreated1997-11-20lld:pubmed
pubmed-article:9308821pubmed:abstractTextThe aim of this study was to assess how effectively the Rovumeter, designed for the volumetric self-sampling of cervicovaginal fluid (CVF), can be used to locate the minimum period of potential fertility (PPF) during ovulatory cycles. A multicentre, prospective study was undertaken of volunteers (attending natural family planning clinics) over three consecutive, apparently normal, menstrual cycles. All women collected daily samples of early morning urine and CVF and recorded the volumes (to the nearest 1.0 and 0.1 ml respectively). The concentrations of oestrone glucuronide (EG), luteinizing hormone (LH) and pregnanediol glucuronide (PG) were measured in all samples of early morning urine by immunoassay. A preliminary data set was used to optimize an algorithm to detect the start and end of potential fertility from the volumes of CVF. The end-points used were the normality of each menstrual cycle from its length, the length of luteal phase, and concentrations of EG, LH and PG, the start and end days of potential fertility from CVF volumes, and the minimum PPF, which was defined as the day of the LH peak minus 3 to day plus 2 inclusive. Overall, 72 women (median age 30 years, range 24-38) were recruited from three centres (23 from Birmingham, 24 from Milan, 25 from Santiago) and contributed data from 235 menstrual cycles (median length 28 days, range 23-44). The urinary LH peak was identified in 228 cycles (97%; median time, day 15 from day 1 of last menses, with range day 10 to day 35). The use of the Rovumeter gave start and end signals of potential fertility during 138 cycles (59%). The median length of the derived PPF was 8 days (range 4-18). The signals covered the defined, minimum PPF in 113 cycles [i.e. 50% of those with an LH peak; range 28% (Milan) to 62% (Birmingham)]. Overall 16/72 women (22%) had successful tests over three consecutive menstrual cycles [range 2/24 (8%; Milan) to 8/23 (35%; Birmingham)]. We conclude that signals from daily changes in the volume of CVF as determined by the use of the Rovumeter consistently locate the minimum period of potential fertility in only a small proportion of women.lld:pubmed
pubmed-article:9308821pubmed:languageenglld:pubmed
pubmed-article:9308821pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9308821pubmed:citationSubsetIMlld:pubmed
pubmed-article:9308821pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9308821pubmed:statusMEDLINElld:pubmed
pubmed-article:9308821pubmed:monthAuglld:pubmed
pubmed-article:9308821pubmed:issn0268-1161lld:pubmed
pubmed-article:9308821pubmed:authorpubmed-author:FlynnA MAMlld:pubmed
pubmed-article:9308821pubmed:authorpubmed-author:CollinsW PWPlld:pubmed
pubmed-article:9308821pubmed:authorpubmed-author:RoystonPPlld:pubmed
pubmed-article:9308821pubmed:authorpubmed-author:BarbatoMMlld:pubmed
pubmed-article:9308821pubmed:authorpubmed-author:AlliendeM EMElld:pubmed
pubmed-article:9308821pubmed:authorpubmed-author:Mena-Gonzalez...lld:pubmed
pubmed-article:9308821pubmed:issnTypePrintlld:pubmed
pubmed-article:9308821pubmed:volume12lld:pubmed
pubmed-article:9308821pubmed:ownerNLMlld:pubmed
pubmed-article:9308821pubmed:authorsCompleteYlld:pubmed
pubmed-article:9308821pubmed:pagination1826-31lld:pubmed
pubmed-article:9308821pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9308821pubmed:meshHeadingpubmed-meshheading:9308821-...lld:pubmed
pubmed-article:9308821pubmed:meshHeadingpubmed-meshheading:9308821-...lld:pubmed
pubmed-article:9308821pubmed:meshHeadingpubmed-meshheading:9308821-...lld:pubmed
pubmed-article:9308821pubmed:meshHeadingpubmed-meshheading:9308821-...lld:pubmed
pubmed-article:9308821pubmed:meshHeadingpubmed-meshheading:9308821-...lld:pubmed
pubmed-article:9308821pubmed:meshHeadingpubmed-meshheading:9308821-...lld:pubmed
pubmed-article:9308821pubmed:meshHeadingpubmed-meshheading:9308821-...lld:pubmed
pubmed-article:9308821pubmed:meshHeadingpubmed-meshheading:9308821-...lld:pubmed
pubmed-article:9308821pubmed:meshHeadingpubmed-meshheading:9308821-...lld:pubmed
pubmed-article:9308821pubmed:meshHeadingpubmed-meshheading:9308821-...lld:pubmed
pubmed-article:9308821pubmed:meshHeadingpubmed-meshheading:9308821-...lld:pubmed
pubmed-article:9308821pubmed:year1997lld:pubmed
pubmed-article:9308821pubmed:articleTitleVolumetric self-sampling of cervicovaginal fluid to determine potential fertility: a multicentre pre-effectiveness study of the Rovumeter.lld:pubmed
pubmed-article:9308821pubmed:affiliationNatural Family Planning Unit, Birmingham Maternity Hospital, UK.lld:pubmed
pubmed-article:9308821pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9308821pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:9308821pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:9308821pubmed:publicationTypeMulticenter Studylld:pubmed